From sudden outbreaks to seasonal illnesses 2025 saw an array of events that affected people all across the globe As the year comes to an end let’s do a quick roundup of top 10 biggest disease outbrea ...

Is there a vaccine for the Nipah virus? Early human trials show a new vaccine is safe and triggers strong immune responses.

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...

It can cause significant health issues. Scientists issue warning on concerning trend driving spread of disease: 'Global ...

Find out how different vaccines for the coronavirus cause your body to create antibodies that fight the virus.

TheFly reported on December 19 that BMRN announced it will acquire Amicus Therapeutics in an all‑cash transaction valued at ...

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...

Minaris will move its center for viral vector innovation to occupy space within CGT Catapult's collaborator laboratories in London and will work with CGT Catapult on the further development of ...

Bluetongue virus (BTV) restrictions on animal movements are to be eased in Northern Ireland. It follows several weeks of ...

The firm is submitting data showing that a one-time treatment with ST-920 led to a positive annualized estimated glomerular filtration rate slope.

Findings from two clinical trials suggest Novartis' Itvisma is safe and effective for SMA patients over 2 years old.